Our results are consistent with a model (Figure 8), in which PAX3 inhibits thyroid tumorigenesis by inducing cell cycle arrest and apoptosis, and suppressing tumor metastasis through blocking the PI3K/Akt and MAPK pathways and promoting FOXO3a activity. Here, FOXO3 is linked to thyroid gland disorder.